The veterinary contract manufacturing and research market is poised to expand from USD 6.38 billion in 2026 to USD 9.24 billion by 2031, at a CAGR of 7.7%. Key growth drivers include the rising demand for outsourcing development and manufacturing services and the increasing complexity of veterinary biologics and precision animal health. The companion animals segment is the fastest-growing, driven by pet ownership and demand for innovative therapeutics. The Asia Pacific region is projected to see